Teva Pharmaceutical Industries' net profit under GAAP for 6 months of 2020 was $78 million, compared to a loss of $768 million in the previous year. Revenues decreased by 1.2% to $8.227 billion compared to $8.326 billion a year earlier.
Teva Pharmaceutical Industries' net profit under GAAP for 6 months of 2020 was $78 million, compared to a loss of $768 million in the previous year. Revenues decreased by 1.2% to $8.227 billion compared to $8.326 billion a year earlier. 
ir.tevapharm.com
English (US) 